Table 3.
Univariate and multivariate analysis in preoperative clinicopathological parameters.
Parameter | Univariate | Multivariates | |||||
---|---|---|---|---|---|---|---|
Hazard ratio | 95% C.I. | P value | Hazard ratio | 95% C.I. | P value | ||
Age (continuous) | 0.984 | 0.944–1.027 | 0.462 | N.A. | |||
Biopsy Gleason score | |||||||
6 or less | 1 | 1 | |||||
7 | 1.269 | 0.663–2.430 | 0.472 | 0.658 | 0.281–1.543 | 0.336 | |
8–10 | 4.103 | 2.199–7.656 | <0.001 | 0.925 | 0.312–2.739 | 0.888 | |
| |||||||
Clinical stage | |||||||
T1 | 1 | 1 | |||||
T2 | 1.719 | 1.048–2.819 | 0.032 | 1.191 | 0.652–2.177 | 0.567 | |
T3 | 4.298 | 0.583–31.654 | 0.152 | 4.037 | 0.507–32.121 | 0.187 | |
| |||||||
PSA at biopsy (ng/mL) | |||||||
10 or less | 1 | 1 | |||||
10–20.0 | 1.543 | 0.892–2.668 | 0.121 | 0.961 | 0.398–2.324 | 0.930 | |
Greater than 20 | 4.555 | 2.314–8.965 | <0.001 | 0.892 | 0.258–3.089 | 0.857 | |
| |||||||
% positive cores | |||||||
Less than 34 | 1 | 1 | |||||
34–50 | 1.139 | 0.444–2.920 | 0.787 | 1 | 0.333–2.999 | 1.000 | |
50 or greater | 2.340 | 1.384–3.956 | 0.002 | 1.807 | 0.949–3.444 | 0.072 | |
| |||||||
Calculated cancer volume (mL) | |||||||
2.0 or less | 1 | 1 | |||||
2.0–4.0 | 2.716 | 1.323–5.577 | 0.006 | 3.022 | 1.144–7.981 | 0.026 | |
Greater than 4.0 | 7.116 | 3.595–14.085 | <0.001 | 6.962 | 1.755–27.624 | 0.006 |
N.A.: not available. C.I: confidence interval.